bpc-157 andrew huberman Benefits & Risks of Peptide Therapeutics for Physical & Mental Health joe rogan andrew huberman bpc

Socit Internationale dUrologie J

Welcome back By clicking Continue to join or sign in, you agree to LinkedIns User Agreement, Privacy Policy, and Cookie Policy

Phase 2 Clinical Trial Data The landmark Phase 2 trial of retatrutide in obesity was a 48-week, randomized, double-blind, placebo-controlled study published in The New England Journal of Medicine in 2023

GHK-Cu: Copper tripeptide evaluated for up-regulation of growth factors (e.g., TGF-related pathways), collagen production, and antioxidant activity

While we focus on a variety of skin and wellness treatments, understanding the broader landscape of metabolic health helps you make better decisions for your long-term lifestyle